About 700 reports

Diuretics Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global diuretics drugs market as it emerges from the Covid 19 shut down. Description: Where is the largest and fastest growing market...

  • Pharmacy
  • Marketing Research
  • Heart Failure
  • World

##.##.## Diuretics

  • Renal Disease
  • North America
  • Drug Approval
  • Final Consumption Expenditures

Abstract: - Global Cardiovascular Drugs Market to Reach $80 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cardiovascular Drugs estimated at US$79.8 Billion in the year 2020, is projected to reach a revised size of US$80 Billion by 2027, growing at a CAGR of 0% over the analysis period 2020-2027....

  • Cardiovascular Drug
  • World
  • China
  • United States

##.##.## Diuretics

  • Renal Disease
  • Middle East
  • Africa
  • Diabetes Prevalence
  • Overweight Prevalence

Abstract: - Global Anti-Hypertensive Drugs Market to Reach $33.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Hypertensive Drugs estimated at US$32.7 Billion in the year 2020, is projected to reach a revised size of US$33.2 Billion by 2027, growing at a CAGR of 0.2% over the analysis period...

  • Antihypertensive
  • World
  • China
  • United States

Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026 The...

  • Antihypertensive
  • In-Store Retail
  • Pharmacy
  • Calcium Channel Blocker
  • World
  • APAC
  • Europe

##.##.## Diuretics

  • Renal Disease
  • Central America
  • Brazil
  • Argentina
  • Patients Undergoing Dialysis
  • Health Expenditure

Abstract: - Global Acute Heart Failure (AHF) Therapeutics Market to Reach $1.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Acute Heart Failure (AHF) Therapeutics estimated at US$372.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of...

  • Therapy
  • Heart Failure
  • World
  • China
  • United States

##.##.## Diuretics

  • Renal Disease
  • Europe
  • Health Expenditure
  • Mortality Rate

##.##.## Diuretics

  • Renal Disease
  • APAC
  • Patients Undergoing Dialysis
  • Health Expenditure

Major companies in the genito-urinary drugs market include Daiichi Sankyo Company; Pfizer Inc; Bayer AG; Astellas Pharma Inc and Allergan Plc. The global genito-urinary drugs market is expected to grow from $49.24 billion in 2020 to $53.78 billion in 2021 at a compound annual growth rate (CAGR) of 9.2%. The growth is mainly due to the...

  • Pharmaceutical
  • Incontinence Product
  • Genitourinary System Disease
  • Dysfunction Drug
  • World
  • Health Expenditure
  • Population Over Age Of 65

Antihypertensive Drugs Market – Scope of the Report This report on the global antihypertensive drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027.The report provides the overall...

  • Antihypertensive
  • World

Report Scope: The current report offers a detailed analysis of the antihypertensive drug market.The study includes a discussion of antihypertensive drugs prescribed for lowering the high blood pressure and for the treatment of pulmonary arterial hypertension (PAH). The report excludes drugs used in the treatment...

  • Antihypertensive
  • World
  • Europe
  • North America
  • China
  • Japan
  • Middle East
  • United States
  • APAC
  • Italy
  • United Kingdom
  • Canada
  • Spain
  • France
  • Germany
  • India
  • South America
  • Russia
  • Mexico
  • Africa

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd. and Pfizer, Inc. The global anti-hypertensive drugs market is expected to decline from $26.1 billion in 2019 to $23.5 billion in 2020 at a compound annual growth rate (CAGR) of -9.7%. The...

  • Antihypertensive
  • World
  • United States
  • APAC
  • Cause-Specific Mortality Rate

Amyloidosis can be managed by transplant and, medication such as diuretics and chemotherapy drugs.

  • Therapy
  • Pharmaceutical
  • Endocrine Disease
  • World
  • United Kingdom
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Treatment includes antibiotics and diuretics.

  • Genitourinary System Disease
  • World
  • Surgical Procedures Performed
  • Drug Approval

Figure ##. Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

  • Renal Disease
  • APAC
  • World
  • Chronic Disease Prevalence
  • Health Expenditure

Treatm ent i ncludes antibiotics, anti-i nfl ammatory m edicines to reduce s welling and diuretics to remove excess wat er from the body.

  • Therapy
  • Cardiovascular Disease
  • World
  • Sweden
  • Child Mortality
  • Drug Approval

Treatment includes phosphate binders and diuretics.

  • Therapy
  • Pharmaceutical
  • World
  • China
  • Patients Undergoing Dialysis
  • Drug Approval

Treatment includes antihypertensive drugs and diuretics.

  • Renal Disease
  • World
  • Drug Approval
  • Life Insurance Claims

Amyloidosis can be managed by transplant and, medication such as diuretics and chemotherapy drugs.

  • Therapy
  • Endocrine Disease
  • World
  • Sweden
  • Switzerland
  • Indiana
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Treatment includes antibiotics, anti-inflammatory medicines to reduce swelling and diuretics to remove excess water from the body.

  • Cardiovascular Disease
  • World
  • Sweden
  • Drug Approval

Supportive treatment includes diuretics, calcium channel blockers, beta blockers, angiotensin receptor blockers and angiotensin converting enzyme (ACE) inhibitors.

  • Therapy
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Risk factors include congenital heart disease and severe respiratory o r l ung infection, premature babies who have a l ow bi rth weight seem to be at greater risk for developing BPD. Treatment includes bronchodilators, diuretics and antibiotics.

  • Therapy
  • Drug Development
  • World
  • Drug Approval
  • Perinatal Mortality

Treatment includes Oral preparations of phosphates and diuretics.

  • Therapy
  • Drug Development
  • Pharmaceutical
  • World
  • Mortality Rate
  • Pharmaceutical Registrations

Atherosclerosis Drugs Market – Scope of the Report This report on the global atherosclerosis drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027.The report provides the overall market...

  • Cardiovascular Disease
  • World

Risk factors include congenital heart disease and severe respiratory or lung infection, premature babies who have a low birth weight seem to be at greater risk for developing BPD. Treatment includes bronchodilators, diuretics and antibiotics.

  • Therapy
  • Drug Development
  • World
  • Drug Approval
  • Pharmaceutical Exports

Amyloidosis can be managed by transplant and, medication such as diuretics and chemotherapy drugs.

  • Endocrine Disease
  • World
  • Switzerland
  • Indiana
  • Pharmaceutical Registrations
  • Stem Cell Transplantation

Treatment includes phosphate binders and diuretics.

  • Chronic Disease
  • World
  • Patients Undergoing Dialysis
  • Hospital Occupancy Rate

Treatment includes antibiotics and diuretics.

  • Genitourinary System Disease
  • World
  • Surgical Procedures Performed
  • Drug Approval